Central administration of a nitric oxide precursor abolishes both the hypothalamic serotonin release and the hypophagia induced by interleukin-1beta in obese Zucker rats.
Serotonin-induced anorexia has long been recognized as an important part of the CNS mechanisms controlling energy balance. More recently, interleukin-1beta and nitric oxide have been suggested to influence this control, possibly through modulation of hypothalamic serotonin. The present work aimed at investigating the interaction of these systems. We addressed whether 5-HT is affected during IL-1beta-induced anorexia in obese Zucker rats and the influence of the central NO system on this IL-1beta/5-HT interaction. Using microdialysis, we observed that an intracerebroventricular injection of 10 ng IL-1beta significantly stimulated 5-HT extracellular levels in the VMH, with a peak variation of 102+/-41% above baseline. IL-1beta also significantly reduced the 4-h feeding by 33% and the 24-h feeding by 42%. Contrarily, these effects were absent when IL-1beta was injected 2 h after the i.c.v. administration of 20 microg of the NO precursor L-arginine. The results suggest that, in obese Zucker rats, activation of the serotonergic system in the medial hypothalamus participates in IL-1beta-induced anorexia. Since L-arginine, probably through NO stimulation, abolished both the anorexia and the serotonergic activation, it can be proposed that the NO system, either directly or indirectly, counteracts IL-1beta anorexia. The hypothalamic serotonergic system is likely to mediate this NO effect.
Iuras
Anderson
A
Department of Physiology, Federal University of São Paulo, Rua Botucatu, 862-2 Andar, Vila Clementino, São Paulo, SP 04023-060, Brazil.
Telles
Mônica Marques
MM
Bertoncini
Clélia Rejane Antônio
CR
Ko
Gui Mi
GM
de Andrade
Iracema Senna
IS
Silveira
Vera Lúcia Flor
VL
Ribeiro
Eliane Beraldi
EB
D000818:Animals; D004435:Eating / Q000187:drug effects; D005247:Feeding Behavior / Q000187:drug effects*; D006897:Hydroxyindoleacetic Acid / Q000378:metabolism; D007031:Hypothalamus / Q000187:drug effects* / Q000378:metabolism*; D007375:Interleukin-1 / Q000494:pharmacology*; D017551:Microdialysis; D009569:Nitric Oxide / Q000378:metabolism*; D009765:Obesity / Q000378:metabolism*; D051381:Rats; D011924:Rats, Zucker; D012701:Serotonin / Q000378:metabolism*
D007375:Interleukin-1; D009569:Nitric Oxide; D012701:Serotonin; D006897:Hydroxyindoleacetic Acid